SVF: Fonds ir atvērts ierosinājumiem mainīt Īrijas glābšanas programmas nosacījumus

regulation The recent toberlus with US company Celltex, clash between Regenexx and FDA and some other cases demonstrate the uncertainty in regulation of autologous adult stem cells (AASC) for regenerative [...]By on February 6, 2012 at 5:09 pm[...] all this is that the FDA is completely serious about their views.a0 Look at the note from the FDA here.a0 Fat-based stem cells are a drug according to the FDA.a0 It doesn't matter that they came